Y-Mabs Therapeutics, Inc. 984241109 07/11/2025 To approve, on a non-binding advisory vote basis, the compensation of the Company's named executive officers as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 300000 0 For 300000 FOR Grace Therapeutics, Inc. 00439U104 09/12/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 260091 0 For 260091 FOR Angiodynamics, Inc. 03475V101 11/10/2025 Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 70000 0 For 70000 FOR CNS Pharmaceuticals, Inc. 18978H508 11/17/2025 To vote on a non-binding, advisory proposal on the frequency of holding future votes regarding executive compensation.; To vote on a non-binding, advisory resolution to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 13034 0 For 13034 FOR Rezolute, Inc. 76200L309 11/19/2025 To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers as disclosed in the Executive Compensation section of the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 49700 0 For 49700 FOR AYTU Biopharma, Inc. 054754858 12/10/2025 The advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 774055 0 For 774055 FOR Kamada Ltd. M6240T109 12/10/2025 To adopt an amended and restated Compensation Policy for Executive Officers and Directors SECTION 14A SAY-ON-PAY VOTES ISSUER 20116 0 For 20116 FOR Semler Scientific, Inc. 81684M104 01/13/2026 To approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to the named executive officers of Semler Scientific that arises from or otherwise relates to the Merger SECTION 14A SAY-ON-PAY VOTES ISSUER 45702 0 For 45702 FOR ENANTA PHARMACEUTICALS, INC. 29251M106 03/11/2026 To approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 331 0 For 331 FOR ENANTA PHARMACEUTICALS, INC. 29251M106 03/11/2026 To approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 99669 0 For 99669 FOR Indivior PLC 45579U109 03/18/2026 To approve, on an advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 100000 0 For 100000 FOR X4 Pharmaceuticals, Inc. 98420X202 05/11/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 196 0 For 196 FOR X4 Pharmaceuticals, Inc. 98420X202 05/11/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 408783 0 For 408783 FOR Corbus Pharmaceuticals Holdings, Inc. 21833P301 05/13/2026 Approval, on an advisory basis, of the executive compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 225000 0 For 225000 FOR Corbus Pharmaceuticals Holdings, Inc. 21833P301 05/13/2026 Approval, on an advisory basis, of the executive compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 158462 0 For 158462 FOR Surrozen, Inc. 86889P208 05/13/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 60187 0 For 60187 FOR Surrozen, Inc. 86889P208 05/13/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 399 0 For 399 FOR Phathom Pharmaceuticals, Inc. 71722W107 05/19/2026 To approve the compensation of the named executive officers on a non-binding advisory basis ("say-on-pay") SECTION 14A SAY-ON-PAY VOTES ISSUER 42729 0 For 42729 FOR Curis, Inc. 231269309 05/19/2026 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 165076 0 For 165076 FOR Curis, Inc. 231269309 05/19/2026 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 3333334 0 For 3333334 FOR Mannkind Corporation 56400P706 05/20/2026 To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKind's proxy statement for the Annual Meeting SECTION 14A SAY-ON-PAY VOTES ISSUER 10000 0 For 10000 FOR Xoma Corporation 98419J206 05/21/2026 Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 69500 0 For 69500 FOR Verastem, Inc. 92337C203 05/21/2026 To approve an advisory vote on the compensation of the named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 1913655 0 For 1913655 FOR Verastem, Inc. 92337C203 05/21/2026 To approve an advisory vote on the compensation of the named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 1366345 0 For 1366345 FOR Establishment Labs Holdings Inc. G31249108 05/22/2026 To approve, on an advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 6000 0 For 6000 FOR Edesa Biotech Inc 27966L306 05/27/2026 Advisory Vote on Executive Compensation: Approve, on an advisory basis, our executive compensation (""Say on Pay"") SECTION 14A SAY-ON-PAY VOTES ISSUER 30000 0 For 30000 FOR Neumora Therapeutics, Inc. 640979100 05/27/2026 Advisory vote on the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 100000 0 For 100000 FOR ADMA Biologics, Inc. (ADMA) 000899104 06/02/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 740000 0 For 740000 FOR Crescent Biopharma, Inc. G2545C104 06/02/2026 To approve, on a non-binding, advisory basis, the compensation of Crescent Biopharma, Inc.'s named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 80998 0 For 80998 FOR Kalaris Therapeutics, Inc. 482929106 06/03/2026 The approval of an advisory vote on executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 20400 0 For 20400 FOR Xeris Biopharma Holdings, Inc. 98422E103 06/04/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officer SECTION 14A SAY-ON-PAY VOTES ISSUER 40030 0 For 40030 FOR Pulmonx Corporation 745848101 06/04/2026 To conduct a non-binding advisory vote to approve our executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 768288 0 For 768288 FOR PMV Pharmaeuticals Inc. 69353Y103 06/04/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 708102 0 For 708102 FOR Si-Bone, Inc. 825704109 06/04/2026 Advisory vote to approve executive compensation "Say-on-Pay SECTION 14A SAY-ON-PAY VOTES ISSUER 14964 0 For 14964 FOR Nektar Therapeutics 640268306 06/04/2026 To approve a non-binding advisory resolution regarding our executive compensation (a "say-on-pay" vote) SECTION 14A SAY-ON-PAY VOTES ISSUER 20000 0 For 20000 FOR Nektar Therapeutics 640268306 06/04/2026 To approve a non-binding advisory resolution regarding our executive compensation (a "say-on-pay" vote) SECTION 14A SAY-ON-PAY VOTES ISSUER 60000 0 For 60000 FOR Verrica Pharmaceuticals Inc. 92511W207 06/05/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 75000 0 For 75000 FOR Cabaletta Bio, Inc. 12674W109 06/09/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 50000 0 For 50000 FOR Tela Bio, Inc. 872381108 06/09/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2617252 0 For 2617252 FOR Ovid Therapeutics, Inc. 690469101 06/10/2026 Advisory approval of the compensation paid to our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 40000 0 For 40000 FOR Pliant Therapeutics, Inc. 729139105 06/11/2026 To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 224650 0 For 224650 FOR Abeona Therapeutics, Inc. 00289Y206 06/11/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 746587 0 For 746587 FOR Janux Therapeutics, Inc. 47103J105 06/11/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 10000 0 For 10000 FOR Heron Therapeutics, Inc. 427746102 06/11/2026 To approve, on a nonbinding advisory basis, compensation paid to our Named Executive Officers during the fiscal year ended December 31, 2025 SECTION 14A SAY-ON-PAY VOTES ISSUER 1402191 0 For 1402191 FOR Evolus, Inc. 30052C107 06/11/2026 Approval of, on an advisory basis, the compensation of Evolus' named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 1759091 0 For 1759091 FOR Cellectar Biosciences, Inc. 15117F880 06/12/2026 To approve, on a non-binding advisory basis, named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 149879 0 For 149879 FOR Zentalis Pharmaceuticals, Inc. 98943L107 06/16/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 245500 0 For 245500 FOR Codexis, Inc. 192005106 06/17/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 225000 0 For 225000 FOR Adicet Bio, Inc. 007002207 06/17/2026 To ratify, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 213500 0 For 213500 FOR Cytomx Therapeutics, Inc. 23284F105 06/17/2026 To approve, on a nonbinding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders. SECTION 14A SAY-ON-PAY VOTES ISSUER 200000 0 For 200000 FOR Cytomx Therapeutics, Inc. 23284F105 06/17/2026 To approve, on a nonbinding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders. SECTION 14A SAY-ON-PAY VOTES ISSUER 5000 0 For 5000 FOR Arvinas, Inc. 04335A105 06/24/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 27500 0 For 27500 FOR Inhibikase Therapeutics, Inc. 45719W205 06/26/2026 to approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 313 0 For 313 FOR Inhibikase Therapeutics, Inc. 45719W205 06/26/2026 to approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 800544 0 For 800544 FOR